Davenport & Co’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-38
| Closed | -$26.8K | – | 1091 |
|
|
2023
Q3 | $26.8K | Buy |
38
+3
| +9% | +$2.11K | ﹤0.01% | 1022 |
|
|
2023
Q2 | $162K | Hold |
35
| – | – | ﹤0.01% | 993 |
|
|
2023
Q1 | $93.7K | Hold |
35
| – | – | ﹤0.01% | 1003 |
|
|
2022
Q4 | $92K | Hold |
35
| – | – | ﹤0.01% | 963 |
|
|
2022
Q3 | $140K | Hold |
35
| – | – | ﹤0.01% | 926 |
|
|
2022
Q2 | $92K | Hold |
35
| – | – | ﹤0.01% | 946 |
|
|
2022
Q1 | $114K | Sell |
35
-20
| -36% | -$65.1K | ﹤0.01% | 1010 |
|
|
2021
Q4 | $343K | Sell |
55
-12
| -18% | -$74.8K | ﹤0.01% | 844 |
|
|
2021
Q3 | $623K | Sell |
67
-4
| -6% | -$37.2K | ﹤0.01% | 668 |
|
|
2021
Q2 | $722K | Buy |
71
+8
| +13% | +$81.4K | 0.01% | 550 |
|
|
2021
Q1 | $1.21M | Buy |
63
+27
| +75% | +$519K | 0.01% | 353 |
|
|
2020
Q4 | $216K | Buy |
+36
| New | +$216K | ﹤0.01% | 729 |
|
|
2020
Q3 | – | Sell |
-5
| Closed | -$20K | – | 759 |
|
|
2020
Q2 | $20K | Hold |
5
| – | – | ﹤0.01% | 702 |
|
|
2020
Q1 | $10K | Buy |
+5
| New | +$10K | ﹤0.01% | 662 |
|